Most bought healthcare stocks in Q2 2023
See which Healthcare stocks institutional investors increased the most in Q2 2023, measured as net growth in reported share positions from Q1 2023 into Q2 2023. Notable additions at the top of this list include AVANTOR INC (AVTR), PRIVIA HEALTH GROUP INC (PRVA), DANAHER CORP (DHR), THERMO FISHER SCIENTIFIC INC (TMO). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AVTR | AVANTOR INC | 6,885,490 | $3.85M | 0 | 3 | 2 | 0 | 6 |
| PRVA | PRIVIA HEALTH GROUP INC | 4,219,964 | $118.71M | 1 | 1 | 1 | 0 | 3 |
| DHR | DANAHER CORP | 3,833,285 | $901.30M | 2 | 5 | 3 | 0 | 14 |
| TMO | THERMO FISHER SCIENTIFIC INC | 2,893,044 | $1.14B | 1 | 6 | 5 | 1 | 13 |
| BFLY | BUTTERFLY NETWORK INC | 2,874,575 | $11.56M | 0 | 1 | 0 | 1 | 1 |
| AGL | AGILON HEALTH INC | 2,176,399 | -$26.19M | 0 | 3 | 0 | 0 | 3 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 1,999,380 | $2.15K | 0 | 1 | 0 | 0 | 1 |
| VSTM | VERASTEM INC | 1,958,957 | $14.03M | 2 | 0 | 0 | 0 | 2 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,900,829 | -$30.08M | 0 | 2 | 2 | 0 | 5 |
| OPCH | OPTION CARE HEALTH INC | 1,886,273 | $77.97M | 1 | 0 | 1 | 2 | 2 |
| SENS | SENSEONICS HOLDINGS INC | 1,779,445 | $1.36K | 1 | 0 | 0 | 0 | 1 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | 1,437,613 | $54.92M | 1 | 0 | 0 | 0 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 1,323,675 | $1.19K | 0 | 1 | 0 | 0 | 1 |
| ABBV | ABBVIE INC | 1,301,513 | $37.79M | 1 | 4 | 4 | 0 | 11 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 1,193,127 | -$74.72M | 0 | 1 | 1 | 0 | 3 |
| QSI | QUANTUM-SI INC | 1,166,140 | $2.24M | 0 | 2 | 0 | 0 | 2 |
| RXRX | RECURSION PHARMACEUTICALS-A | 1,096,094 | $11.54M | 0 | 1 | 1 | 0 | 2 |
| NKTR | NEKTAR THERAPEUTICS | 1,087,985 | $243 | 0 | 1 | 0 | 0 | 1 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,044,815 | $13.32M | 0 | 2 | 0 | 0 | 2 |
| LFST | LIFESTANCE HEALTH GROUP INC | 994,937 | $8.61M | 2 | 0 | 0 | 0 | 2 |
| AKBA | AKEBIA THERAPEUTICS INC | 992,227 | $1.74K | 0 | 1 | 0 | 0 | 1 |
| ME | 23ANDME HOLDING CO -CLASS A | 977,329 | $898 | 0 | 1 | 0 | 0 | 1 |
| VKTX | VIKING THERAPEUTICS INC | 885,243 | $24.89M | 0 | 1 | 1 | 0 | 2 |
| MREO | MEREO BIOPHARMA GROUP PL-ADR | 862,863 | $1.70K | 0 | 1 | 0 | 0 | 1 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 836,200 | $18.82M | 0 | 1 | 0 | 1 | 1 |
| TDOC | TELADOC HEALTH INC | 798,240 | -$17.99M | 0 | 1 | 1 | 0 | 2 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 780,225 | $1.12M | 0 | 2 | 0 | 0 | 2 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 760,064 | $9.71M | 0 | 1 | 1 | 0 | 2 |
| VXRT | VAXART INC | 735,548 | $535 | 0 | 1 | 0 | 0 | 1 |
| AQST | AQUESTIVE THERAPEUTICS INC | 711,396 | $1.44K | 0 | 1 | 0 | 0 | 1 |
| CMRX | CHIMERIX INC | 705,538 | $785 | 0 | 1 | 0 | 0 | 1 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 669,650 | -$986.78K | 0 | 2 | 1 | 0 | 3 |
| VERV | VERVE THERAPEUTICS INC | 668,760 | $31.95M | 0 | 1 | 0 | 0 | 1 |
| AVIR | ATEA PHARMACEUTICALS INC | 635,682 | $2.66K | 0 | 1 | 0 | 0 | 1 |
| CI | THE CIGNA GROUP | 591,755 | $459.78M | 0 | 4 | 1 | 0 | 6 |
| BLUE | BLUEBIRD BIO INC | 550,200 | $1.81K | 1 | 0 | 0 | 0 | 1 |
| TGTX | TG THERAPEUTICS INC | 536,200 | $13.32K | 1 | 0 | 0 | 0 | 1 |
| PRME | PRIME MEDICINE INC | 526,922 | $12.24M | 0 | 1 | 0 | 0 | 1 |
| JYNT | JOINT CORP/THE | 479,013 | $7.06M | 0 | 2 | 0 | 0 | 2 |
| TALK | TALKSPACE INC | 465,259 | $836 | 0 | 1 | 0 | 0 | 1 |
| CARA | CARA THERAPEUTICS INC | 430,308 | -$3.51M | 0 | 2 | 0 | 0 | 2 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 428,786 | $17.59M | 0 | 2 | 4 | 0 | 8 |
| ALT | ALTIMMUNE INC | 382,400 | $1.16K | 0 | 1 | 0 | 0 | 1 |
| IQV | IQVIA HOLDINGS INC | 381,964 | $146.32M | 0 | 3 | 1 | 0 | 4 |
| A | AGILENT TECHNOLOGIES INC | 378,975 | -$27.19M | 0 | 2 | 2 | 0 | 5 |
| PFMT | PERFORMANT FINANCIAL CORP | 369,080 | $241.59K | 0 | 1 | 1 | 0 | 2 |
| ATYR | ATYR PHARMA INC | 368,700 | $806 | 0 | 1 | 0 | 0 | 1 |
| ATEC | ALPHATEC HOLDINGS INC | 357,500 | $6.43K | 1 | 0 | 0 | 0 | 1 |
| EQ | EQUILLIUM INC | 353,531 | $266 | 0 | 1 | 0 | 0 | 1 |
| ACLX | ARCELLX INC | 328,167 | $10.39K | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2023
What are the most bought Healthcare stocks in Q2 2023?
The most bought healthcare stocks in Q2 2023 are those with the largest increase in reported share counts across tracked institutional investors compared to Q1 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2023?
Among the managers we track, net additions were largest in companies such as AVANTOR INC (AVTR), PRIVIA HEALTH GROUP INC (PRVA), DANAHER CORP (DHR), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q1 2023).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.